Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatory light chain mutations affect myosin motor function and kinetics.

B M Chaudoir1, P A Kowalczyk, R L Chisholm

  • 1Dept of Cell and Molecular Biology, Northwestern University Medical School, Ward 11-100, Chicago, IL 60611-3008, USA.

Journal of Cell Science
|April 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.

Clinical pharmacology and therapeutics·2016
Same author

A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough.

The pharmacogenomics journal·2015
Same author

Failure of hyperglycemia and hyperinsulinemia to compensate for impaired metabolic response to an oral glucose load.

Journal of diabetes and its complications·2014
Same author

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.

Clinical pharmacology and therapeutics·2014
Same author

The opportunities and challenges of implementing genomics-informed personalized medicine.

Clinical pharmacology and therapeutics·2013
Same author

Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension.

Diabetes, obesity & metabolism·2011

The regulatory light chain (RLC) directly influences myosin II motor protein function, affecting cell division and development. Specific RLC mutations impair myosin

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Motors

Background:

  • Myosin II is crucial for cellular processes in muscle and non-muscle cells.
  • Dictyostelium regulatory light chain (RLC) null mutants exhibit defects in cytokinesis and development.
  • Previous studies showed contradictory results regarding RLC's role, suggesting potential mislocalization of myosin.

Purpose of the Study:

  • To investigate whether the regulatory light chain (RLC) directly impacts myosin II activity.
  • To differentiate between myosin mislocalization and direct RLC influence on myosin function.
  • To analyze the effects of specific RLC point mutations on myosin II performance.

Main Methods:

  • Generated Dictyostelium RLC null mutants expressing three specific RLC point mutations (E12T, G18K, N94A).

Related Experiment Videos

  • Purified mutant Dictyostelium myosin for biochemical and functional analysis.
  • Assessed myosin II binding, phosphorylation, actin-activated ATPase activity, and in vitro motility.
  • Main Results:

    • RLC mutations did not affect RLC binding to myosin heavy chain (MHC) or phosphorylation-dependent regulation.
    • All three RLC mutants displayed reduced myosin function, including impaired cytokinesis and, in one case, defective fruiting body development.
    • Myosin localization defects in RLC null mutants were rescued by expressing the RLC mutants.
    • Mutant myosins showed reduced in vitro motility and, in one case, significantly decreased actin-activated ATPase activity.

    Conclusions:

    • The regulatory light chain (RLC) directly modulates myosin II force transmission and kinetic properties.
    • Specific RLC mutations, analogous to those causing human hypertrophic cardiomyopathy, impair myosin II function.
    • RLC's role extends beyond localization, directly influencing myosin's motor activity.